SEC Form 4 · accession 0001702626-17-000002
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stewart Appelrouth
Director
Period of report
Aug 24, 2016
Accepted (ET)
Mar 31, 2017 · 2:43 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Aug 24, 2016 | P | 15,750 | $2.21 | A | 15,750 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Shares and prices have been adjusted to give retroactive effect to the 1 for 12 reverse stock split effected on 8/29/16.
- F2This transaction was executed in multiple trades at prices ranging from $2.16 to $2.22. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares and prices at which the transaction was effected.